Quantinno Capital Management’s Integra LifeSciences IART Stock Holding History

Quantinno Capital Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.9M	Buy	609,132 +149,703	+33%	+$2.09M	0.01%	945
2026 Q1	$4.33M	Sell	459,429 -382,663	-45%	-$4.2M	0.01%	1203
2025 Q4	$10.5M	Buy	842,092 +601,738	+250%	+$8M	0.02%	763
2025 Q3	$3.44M	Buy	240,354 +162,922	+210%	+$2.23M	0.01%	1049
2025 Q2	$950K	Sell	77,432 -90,888	-54%	-$1.32M	﹤0.01%	1338
2025 Q1	$3.7M	Buy	168,320 +118,972	+241%	+$2.8M	0.02%	779
2024 Q4	$1.12M	Buy	+49,348	New	+$1.08M	0.01%	1021
2024 Q3	–	Sell	-46,689	Closed	-$1.36M	–	1479
2024 Q2	$1.36M	Buy	46,689 +19,864	+74%	+$589K	0.02%	709
2024 Q1	$951K	Sell	26,825 -5,519	-17%	-$221K	0.02%	752
2023 Q4	$1.41M	Buy	32,344 +19,954	+161%	+$785K	0.05%	509
2023 Q3	$473K	Buy	+12,390	New	+$521K	0.02%	738
2023 Q2	–	Sell	-19,081	Closed	-$1.09M	–	928
2023 Q1	$1.09M	Buy	+19,081	New	+$1.08M	0.07%	354
2022 Q3	–	Sell	-10,390	Closed	-$561K	–	633
2022 Q2	$561K	Buy	10,390 +3,616	+53%	+$217K	0.08%	311
2022 Q1	$435K	Buy	+6,774	New	+$446K	0.07%	334
2021 Q4	–	Sell	-5,176	Closed	-$354K	–	521
2021 Q3	$354K	Buy	5,176 +88	+2%	+$6.22K	0.4%	110
2021 Q2	$347K	Hold	5,088	–	–	0.39%	120
2021 Q1	$352K	Sell	5,088 -837	-14%	-$56.7K	0.38%	116
2020 Q4	$385K	Buy	+5,925	New	+$319K	0.3%	157
2020 Q2	–	Sell	-8,732	Closed	-$390K	–	373
2020 Q1	$390K	Buy	+8,732	New	+$458K	0.24%	210
2019 Q4	–	Sell	-5,513	Closed	-$331K	–	443
2019 Q3	$331K	Hold	5,513	–	–	0.22%	228
2019 Q2	$308K	Buy	+5,513	New	+$284K	0.18%	276

Other funds holding IART

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Quantinno Capital Management's IART Position: Q2 2026 in Review

Quantinno Capital Management increased its Integra LifeSciences (IART) stake by 33% in Q2 2026, buying an estimated $2.09M and bringing the position to 609,132 shares worth $10.9M. The position accounts for 0.01% of the portfolio, ranked #945.

Quantinno Capital Management first reported a position in IART in Q2 2019 and has held it in 21 quarters since. 213 funds tracked by Wall St. Rank hold IART as of Q2 2026.

Quantinno Capital Management held 609,132 shares of Integra LifeSciences worth $10.9M as of Q2 2026.
Quantinno Capital Management bought 149,703 Integra LifeSciences shares in Q2 2026, an estimated $2.09M.
Integra LifeSciences made up 0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #945 holding.
Quantinno Capital Management first reported a position in Integra LifeSciences in Q2 2019 and has held it in 21 quarters since.
213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.